An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the pilot stage as an effort to incentivize pharma manufacturers to achieve a more mature state of quality culture.
Sarah Akers
Advertisement
Consultant, Shabas Solutions LLC
Articles by Sarah Akers
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Serious is the Biosimilar Void?
2
Travere Therapeutics’ Filspari Receives Full FDA Approval
3
New Study Reveals Genetic Predictors for GLP-1 Weight Loss and Side Effects
4
Implications of Tecvayli Plus Darzalex Faspro Demonstrating 83% Reduction in Disease Progression or Death.
5